A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data-Reference-Cited by-同舟云学术

A 12-gene panel in estimating hormone-treatment responses of castration-resistant prostate cancer patients generated using a combined analysis of bulk and single-cell sequencing data

Published:2023-09-20 Issue:2 Volume:55 Page:
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Huang Juanlan¹²,Liu Dale²³,Li Jun⁴,Xu Jing²⁵,Dong Shaowei⁴^ORCID,Zhang Hao⁶⁷

Affiliation:

1. Department of Health Management, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, Guangzhou, China

2. The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, China

3. Department of Urology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, Guangzhou, China

4. Department of Hematology and Oncology, Shenzhen Children’s Hospital of China Medical University, Shenzhen, China

5. Department of Pathology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University, Guangzhou, China

6. Department of General Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, China

7. Department of Thyroid, Breast and Hernia Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou, China

Funder

Medical Scientific Research Foundation of Guangdong Province of China

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2260387

Reference35 articles.

1. Cancer statistics, 2022

2. Development and prevalence of castration-resistant prostate cancer subtypes

3. Androgen Deprivation Therapy for Prostate Cancer

4. Emerging therapies in castrate-resistant prostate cancer

5. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MRPL13 is a metastatic and prognostic marker of breast cancer: A silico analysis accompanied with experimental validation;Gene;2025-01

2. Identification of functional and diverse circulating cancer‐associated fibroblasts in metastatic castration‐naïve prostate cancer patients;Molecular Oncology;2024-04-17

3. Correctly identifying the cells of origin is essential for tailoring treatment and understanding the emergence of cancer stem cells and late metastases;Frontiers in Oncology;2024-04-10

4. Bioinformatics Analysis of Single-Cell Transcriptome Based on Prostate Cancer Cancer-Associated Fibroblasts;Hans Journal of Biomedicine;2024